Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $64.8M | $88.2M | $66.3M | $110.3M | $146.4M | $190.1M | $227.0M | $254.9M | $307.1M | $345.3M | $352.9M | $352.4M | $342.3M | $315.6M | $404.6M | $621.7M | $474.5M | $779.4M | $897.6M | $1,021.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, ResMed Inc.'s last 12-month Net Income is $1,248.7M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, ResMed Inc.'s Net Income growth was 40.2%. The average annual Net Income growth rates for ResMed Inc. have been 38.1% over the past three years, 22.4% over the past five years.
Over the last year, ResMed Inc.'s Net Income growth was 40.2%, which is higher than industry growth of 8.8%. It indicates that ResMed Inc.'s Net Income growth is Good.